Leukemia Clinical Trials in Arizona

Showing 241-260 of 670 trials

A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

NCT02990481

1. To determine the maximum tolerated dose (MTD) and the dose limiting toxicities (DLTs) of TRK-950 as single agent 2. To establish the dose of TRK-950 recommended for future phase 2 studies

Locally Advanced or Metastatic Solid CarcinomasColon CancerCholangiocarcinoma

Toray Industries, Inc38 participantsStarted Mar 2017

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Lyon, France

TERMINATEDPHASE238 miles

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

NCT02093962

The purpose of this study is to determine whether TH-302 in combination with pemetrexed is safe and effective in the treatment of non-squamous non-small cell lung cancer.

Non-small Cell Lung Cancer

ImmunoGenesis265 participantsStarted Jun 2014

Birmingham, Alabama, United States • Chandler, Arizona, United States • Encinitas, California, United States +77 more locations

PreviousPage 13 of 34Next

A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

Leukemia Trials in Other Cities

A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

VAY736 in Combination With Ibrutinib in Patients With CLL on Ibrutinib

MAGIC Ruxolitinib for aGVHD

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Study of REM-422 in Patients With AML or Higher Risk MDS

A Study of SEA-CD40 Given With Other Drugs in Cancers

Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients

Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

Other Conditions in Arizona